Answers are grounded in this paper and cite their sources.
We greatly appreciated the editorial by Barratt (1997) concerning the importance of our human fetoembryonic defence system (hu-FEDS) and its corollaries (Clark et al., 1996a; 1997). The ‘danger model’ suggests that antigen presenting cells (APCs) can perceive danger and that recognition of self versus non-self is not important in the scheme of how the immune system reacts to such danger (Matzinger, 1994). Dr Barratt stated in his review that the possibility existed that the developing human did not evoke a ‘danger’ signal that would induce an immune response thus causing fetal rejection. We would argue otherwise. Human implantation is aggressive (for review see Edwards, 1995) and likely to generate crush injuries during this process. The developing human undergoes dramatic tissue remodelling that releases proteins and peptides. This release can evoke humoral responses against foreign paternal or maternal (in the case of surrogacy) major histocompatibility complex (MHC) molecules (Amos and Yunis, 1969; Humphreys et al., 1976). During pregnancy, 2–3 weeks prior to term a clinical development known as ‘cervical ripening’ is observed (for review see Romero et al., 1994). This process is accompanied by a substantial influx of inflammatory cell types into the cervix and decidua. The cause of this influx is not yet known, but it does suggest that a ‘danger signal’ is evoked during pregnancy. It is significant that this cervical ripening correlates temporally with the loss of immunosuppressive factors that are present in the uterus, such as glycodelin-A. Such observations suggest that fetal rejection would occur during pregnancy if not for the existence of a localized immunosuppressive system such as hu-FEDS. Thus these findings lead in turn to a very significant question: is the human birth process itself the result of the loss of this localized immune suppression in the uterus? We believe so, and think that this area represents very fertile ground for future experimentation. We would also like to comment on some new evidence that has recently been reported. Parham and associates recently demonstrated that the major human class I molecules (HLAA, -B and -C) carry the bisecting biantennary type glycan
No takes yet. Share an insight, caveat, or question.
Georgina J. Clark (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: